You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
爾康製藥(300267.SZ):光宇利民藥品生產許可證變更 新增“中藥飲片(含毒性飲片),中藥飲片(直接口服飲片),中藥飲片”的生產範圍、生產線
格隆匯 01-21 20:09

格隆匯1月21日丨爾康製藥(300267.SZ)公佈,公司控股子公司西藏昌都光宇利民藥業有限責任公司(“光宇利民”)於近日取得西藏自治區藥品監督管理局換髮的《藥品生產許可證》。此次變更主要涉及增加中藥飲片生產範圍和生產線:新增“中藥飲片(含毒性飲片),中藥飲片(直接口服飲片),中藥飲片”生產範圍;新增“中藥飲片生產線、中藥飲片(含毒性飲片)生產線、中藥飲片(直接口服飲片)生產線”。新增的生產範圍和生產線已經通過藥品GMP符合性檢查。《藥品生產許可證》的基本信息如下:

企業名稱:西藏昌都光宇利民藥業有限責任公司;註冊地址:西藏昌都西路14號;社會信用代碼:915400007355447702;有效期至:2025年3月4日;許可證編號:藏20200001;生產地址和生產範圍:西藏自治區昌都市經濟開發區C區:丸劑(蜜丸、水丸),散劑,硬膠囊劑,中藥飲片(含毒性飲片),中藥飲片(直接口服飲片),中藥飲片***。

此次光宇利民新增“中藥飲片(含毒性飲片),中藥飲片(直接口服飲片),中藥飲片”的生產範圍、生產線,同時通過了藥品GMP符合性檢查,進一步強化了公司在中藥領域的產業佈局,有利於進一步豐富公司產品品種,完善產品結構,提升生產能力,擴大市場規模,提高公司核心競爭力。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account